EP Patent

EP2961390A1 — Pharmaceutical formulations comprising quetiapine and escitalopram

Assigned to Sanovel Ilac Sanayi ve Ticaret AS · Expires 2016-01-06 · 10y expired

What this patent protects

The present invention relates to a multilayer tablet formulation comprising a combination of quetiapine or a pharmaceutically acceptable salt thereof and escitalopram or a pharmaceutically acceptable salt thereof.

USPTO Abstract

The present invention relates to a multilayer tablet formulation comprising a combination of quetiapine or a pharmaceutically acceptable salt thereof and escitalopram or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number: EP2961390A1
Jurisdiction: EP
Classification: —
Expires: 2016-01-06
Drug substance claim: No
Drug product claim: No
Assignee: Sanovel Ilac Sanayi ve Ticaret AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.